Status quo.. With the latest Nomura report for the first time, I cannot share it on the forum ,its a 12 page document tried many times but it will not copy ..its good .. One of the points says it sends a powerfull signal to TEVA,s investment... regarding a positive trial out come......My thinking on that point is , I am so sure that CEPH.. TEVA .. LONZA ..And lets be realistic have advanced around $2bill into MSB .. LONZA are not included in that figure Yet but for the holders of MSB most know the conditions with the LONZA deal .... Also be aware The stem cell(adult stem cell) is gaining world wide status continuous, while embryonic stem cell issues are being put on hold world wide ... Not given up trying to send V
MSB Price at posting:
$7.58 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)